PI-3-KD-IN-015

N/A

Report date: 2022/01/05 15:24:33
NME

Base Information

Drug NamePI-3-KD-IN-015
Drug Alias NamePI-3-KD-IN-015
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphatidylinositol 3 kinase delta inhibitors
TargetsPhosphatidylinositol 3 kinase delta
Therapy Area/IndicationsLeukemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesHefei Cosource Medicine TechnologyHefei Academy Of Physical Sciences, Chinese Academy Of Sciences
China Registration ClassN/A

Develop Information

Active CompaniesHefei Academy Of Physical Sciences, Chinese Academy Of SciencesHefei Cosource Medicine Technology
Inactive CompaniesN/A
Active IndicationsLeukemia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A